Antihypertensive drugs and cancer risk

S Kidoguchi, N Sugano, T Yokoo… - American Journal of …, 2022 - academic.oup.com
Hypertension is the most prevalent comorbidity in cancer patients. Consequently, many
cancer patients are prescribed antihypertensive drugs before cancer diagnosis or during …
被引用次数：8 相关文章

Antihypertensive Drugs and Cancer Risk

S Kidoguchi, N Sugano, T Yokoo… - American journal …, 2022 - pubmed.ncbi.nlm.nih.gov
Hypertension is the most prevalent comorbidity in cancer patients. Consequently, many
cancer patients are prescribed antihypertensive drugs before cancer diagnosis or during …

Antihypertensive Drugs and Cancer Risk.

S Kidoguchi, N Sugano, T Yokoo… - American Journal of …, 2022 - search.ebscohost.com
Hypertension is the most prevalent comorbidity in cancer patients. Consequently, many
cancer patients are prescribed antihypertensive drugs before cancer diagnosis or during …

Antihypertensive Drugs and Cancer Risk

S Kidoguchi, N Sugano, T Yokoo… - American Journal of …, 2022 - academic.oup.com
Hypertension is the most prevalent comorbidity in cancer patients. Consequently, many
cancer patients are prescribed antihypertensive drugs before cancer diagnosis or during …

Antihypertensive Drugs and Cancer Risk

S Kidoguchi, N Sugano, T Yokoo, H Kaneko… - American Journal of …, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Hypertension is the most prevalent comorbidity
in cancer patients. Consequently, many cancer patients are prescribed antihypertensive …